HealthStream, Inc.

The current price of HSTM is $28.89 — it has decreased by 2.40% since the previous close. Data as of Nov 6, 2026.

HSTM is down 14.32% over the past week, down 10.00% over the past month and up 17.20% over the past year. The price is above its 200-day moving average of $25.82.

Analysts' average 12-month price target for HSTM is $27.00, which implies 6.54% downside from the current price. Individual estimates range from $27.00 to $27.00.

Of the 7 analysts covering HealthStream, Inc., 2 rate it a buy and 5 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.

HealthStream, Inc. has a market capitalization of $883.92M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, HealthStream, Inc. posted earnings of $0.18 per share against an estimate of $0.1583, beating expectations by 13.71%. Upcoming reports are listed in the earnings calendar.

HealthStream, Inc. reported revenue of $83.31M in its most recent quarter, which has increased by 8.94% compared with the same quarter a year earlier. Analysts had expected $82.24M.

Yes. HealthStream, Inc. pays dividends quarterly. The latest payment of $0.035 per share has a payment date of Nov 27, 2026, which corresponds to a dividend yield of 0.48%.

Companies most comparable to HealthStream, Inc. include Privia Health Group, Inc., Phreesia, Inc., NRC Health, Evolent Health, Inc. and American Well Corporation.

In the latest trading session HSTM moved between $28.72 and $31.03, a range of 7.98% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of HealthStream, Inc. shows a strong sell rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for HealthStream, Inc. is buy. Technical ratings are indicators, not investment advice.

Over the past 52 weeks HSTM has traded between $19.50 and $35.60. The current price is 18.85% below its 52-week high.